← All Stories
Earnings

Sweetgreen Faces Consumer Backlash Amid Cyclospora Outbreak

Sweetgreen's sales are impacted by consumer avoidance amid a cyclospora outbreak, despite no direct link to the company.

Sarah Chen • Aug 13, 2026
Earnings

Air Canada Restores Financial Confidence Amid Fuel Price Volatility Risks

Air Canada reinstates its financial forecast, signaling confidence amidst fuel price volatility risks due to geopolitical tensions.

Sarah Chen • Aug 12, 2026
Earnings

eToro's Bold $231M TradeZero Acquisition and Q2 Earnings Beat: Implications for Retail Brokerage

eToro's acquisition of TradeZero for $231M and strong Q2 earnings signal a strategic shift in the retail brokerage arena.

Sarah Chen • Aug 11, 2026
Earnings

Teledyne's $1.1B Acquisition of Varex Imaging: What It Means for Investors and Traders

Teledyne's acquisition of Varex Imaging has implications for traders and investors, highlighted by a 47% surge in VREX shares.

Sarah Chen • Aug 10, 2026
Earnings

Hertz Earnings Surprise: How the Short Squeeze is Reshaping HTZ Trading Strategies

Hertz's recent earnings report leads to a significant stock price surge, highlighting the dynamics of short squeezes.

Sarah Chen • Aug 7, 2026
Earnings

Biogen's Acquisition of RayThera: A Strategic Move for Investors

Biogen's acquisition of RayThera Inc. could reshape its pipeline and stock potential. Here's what investors need to know.

Sarah Chen • Aug 7, 2026
Earnings

Lucid Group's Q2 Earnings: A Potential Short Squeeze on the Horizon

Lucid Group's Q2 earnings present a significant opportunity for traders, with high short interest indicating a potential short squeeze.

Sarah Chen • Aug 5, 2026
Earnings

Pfizer's Shift to Non-Covid Revenue: A New Era for the Pharma Giant

Pfizer's Q2 earnings beat expectations, signaling a strategic pivot towards non-Covid products and a promising future for investors.

Marcus Rivera • Aug 4, 2026
Earnings

Palantir's AI Revenue Surge: An Indicator of Sustained Growth?

Palantir's stock surged 16% after impressive Q2 earnings, highlighting strong AI demand and implications for future performance.

Sarah Chen • Aug 4, 2026
Earnings

Pfizer's Positive Q2 Results: Navigating Beyond Covid Revenues

Pfizer's latest earnings report reveals a shift from Covid revenues, highlighting a robust non-Covid portfolio.

Marcus Rivera • Aug 4, 2026
Earnings

Palantir's Earnings Surge: A Signal for AI Sector Traders

Palantir shares surged 16% post-earnings, showcasing strong demand for AI tools and reshaping market sentiment.

Sarah Chen • Aug 4, 2026
Earnings

Spider-Man: Brand New Day's Record-Breaking $360M Opening: Implications for Sony's Earnings

Spider-Man's record $360M debut could significantly impact Sony's earnings and related sectors.

Sarah Chen • Aug 3, 2026